Compass Pathways Plc’s shares plummeted after its psychedelic drug to treat a form of depression disappointed investors in a late-stage trial.Most Read from BloombergBezos Wedding Draws Protests, Soul ...

While positive, results from a late-stage clinical trial appear to be raising questions about how useful the company’s ...

Shares of Compass Pathways Plc. (CMPS) slumped 47% on Monday afternoon after the results from the late-stage trials of ...

Compass Pathways’ depression drug trial meets goals but falls short of investor hopes, triggering a sharp share selloff.

The cannabinoid industry is transitioning from early-stage exploration to scientifically validated, regulatory-backed ...

That’s the magic awaiting at Medina Antique Mall in Medina, Ohio – a sprawling wonderland of vintage delights that has treasure hunters from across the Buckeye State plotting road trips with the ...

After two traumatic moments, the Oviedo studio The Artistic Hand lives on thanks to an adoptive family of artists.

Colorado policymakers, including Gov. Jared Polis and Attorney General Phil Weiser, expressed enthusiasm about the potential ...

A TV icon has left Hollywood to pursue a "psychedelic" new career path. Eliza Dushku, star of Bring It On, Buffy the Vampire ...

Thousands of Americans hooked on opioids are heading to Mexico for a radical—and risky—treatment with a powerful psychedelic, ...